Literature DB >> 18628405

Health-related quality of life in patients with high-grade glioma.

Jin-xiang Cheng1, Xiang Zhang, Bo-Lin Liu.   

Abstract

Health-related quality of life (HRQOL) has become an increasingly important endpoint in cancer studies; however, the research into the HRQOL of patients with high-grade glioma (HGG) is sparse compared with that for patients with other neoplasms. Owing to the specific location and poor prognosis, it is more important and difficult to study HRQOL in patients with HGG than in those with other tumors; furthermore, the study of HRQOL in patients with HGG differs from that for patients with other tumors. In this review, we identified and compared the most frequently used instruments to assess HRQOL; analyzed specific facets and determinants of HRQOL (such as sex, tumor location and histological classification, depression, and cognitive function), as well as the association between HRQOL and survival; and appraised the effects of new treatments on HRQOL in patients with HGG from randomized controlled trials. Furthermore, we detected broadly existing problems and many contradictory outcomes and gave some proper interpretation and suggestions regarding them.

Entities:  

Mesh：

Year:  2008        PMID： 18628405      PMCID： PMC2718958          DOI： 10.1215/15228517-2008-050

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


  82 in total

1.  A randomized trial comparing 35Gy in ten fractions with 60Gy in 30 fractions of cerebral irradiation for glioblastoma multiforme and older patients with anaplastic astrocytoma.

Authors:  Claire Phillips; Michael Guiney; Jennifer Smith; Peter Hughes; Kailash Narayan; George Quong
Journal:  Radiother Oncol       Date:  2003-07       Impact factor: 6.280

2.  The use of the mini-mental state examination to assess cognitive functioning in cancer trials: no ifs, ands, buts, or sensitivity.

Authors:  Christina A Meyers; Jeffrey S Wefel
Journal:  J Clin Oncol       Date:  2003-08-11       Impact factor: 44.544

3.  The anatomic basis of delusions after right cerebral infarction.

Authors:  D N Levine; A Grek
Journal:  Neurology       Date:  1984-05       Impact factor: 9.910

4.  Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial.

Authors:  W Roa; P M A Brasher; G Bauman; M Anthes; E Bruera; A Chan; B Fisher; D Fulton; S Gulavita; C Hao; S Husain; A Murtha; K Petruk; D Stewart; P Tai; R Urtasun; J G Cairncross; P Forsyth
Journal:  J Clin Oncol       Date:  2004-03-29       Impact factor: 44.544

5.  Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.

Authors:  Luis Souhami; Wendy Seiferheld; David Brachman; Ervin B Podgorsak; Maria Werner-Wasik; Robert Lustig; Christopher J Schultz; William Sause; Paul Okunieff; Jan Buckner; Lucia Zamorano; Minesh P Mehta; Walter J Curran
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-11-01       Impact factor: 7.038

6.  Depression in patients with high-grade glioma: results of the Glioma Outcomes Project.

Authors:  N Scott Litofsky; Elana Farace; Frederick Anderson; Christina A Meyers; Wei Huang; Edward R Laws
Journal:  Neurosurgery       Date:  2004-02       Impact factor: 4.654

7.  Quality of survival of patients with brain gliomas treated with postoperative CCNU and radiation therapy.

Authors:  T Trojanowski; J Peszyński; K Turowski; P Markiewicz; I Gościński; A Bielawski; B Bendarzewska; J Szymona; A Dabrowska; J Lopatkiewicz
Journal:  J Neurosurg       Date:  1989-01       Impact factor: 5.115

8.  Neuropsychological correlates of rapidly vs. slowly growing intrinsic cerebral neoplasms.

Authors:  J Hom; R M Reitan
Journal:  J Clin Neuropsychol       Date:  1984-08

9.  Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma.

Authors:  Peter Hau; Klaus Fabel; Ulrike Baumgart; Petra Rümmele; Oliver Grauer; Annekatrin Bock; Christopher Dietmaier; Wolfgang Dietmaier; Jörg Dietrich; Christine Dudel; Franz Hübner; Tanya Jauch; Elisabeth Drechsel; Ingo Kleiter; Cäcile Wismeth; Anton Zellner; Alexander Brawanski; Andreas Steinbrecher; Jörg Marienhagen; Ulrich Bogdahn
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

10.  The prognostic value of cognitive functioning in the survival of patients with high-grade glioma.

Authors:  M Klein; T J Postma; M J B Taphoorn; N K Aaronson; W P Vandertop; M Muller; H M van der Ploeg; J J Heimans
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910
View more
  30 in total

1.  Health-related quality of life in high-grade glioma patients: a prospective single-center study.

Authors:  Cagdas Yavas; Faruk Zorlu; Gokhan Ozyigit; Murat Gurkaynak; Guler Yavas; Deniz Yuce; Mustafa Cengiz; Ferah Yildiz; Fadil Akyol
Journal:  Support Care Cancer       Date:  2011-12-13       Impact factor: 3.603

Review 2.  Review on quality of life issues in patients with primary brain tumors.

Authors:  Martin J B Taphoorn; Eefje M Sizoo; Andrew Bottomley
Journal:  Oncologist       Date:  2010-05-27

3.  Quality-adjusted life years in glioma patients: a systematic review on currently available data and the lack of evidence-based utilities.

Authors:  Vicki Marie Butenschoen; Anna Kelm; Bernhard Meyer; Sandro M Krieg
Journal:  J Neurooncol       Date:  2019-06-12       Impact factor: 4.130

4.  Assessment of clinical and nonclinical characteristics associated with health-related quality of life in patients with high-grade gliomas: a feasibility study.

Authors:  Kimberly R Porter; Usha Menon; Nicholas A Vick; John L Villano; Michael L Berbaum; Faith G Davis
Journal:  Support Care Cancer       Date:  2014-01-03       Impact factor: 3.603

5.  Health-related quality of life in patients with high-grade gliomas: a quantitative longitudinal study.

Authors:  K Piil; J Jakobsen; K B Christensen; M Juhler; M Jarden
Journal:  J Neurooncol       Date:  2015-05-31       Impact factor: 4.130

6.  Identifying Voxels at Risk for Progression in Glioblastoma Based on Dosimetry, Physiologic and Metabolic MRI.

Authors:  Mekhail Anwar; Annette M Molinaro; Olivier Morin; Susan M Chang; Daphne A Haas-Kogan; Sarah J Nelson; Janine M Lupo
Journal:  Radiat Res       Date:  2017-07-19       Impact factor: 2.841

7.  Cognitive strategies and quality of life of patients with high-grade glioma.

Authors:  C Lucchiari; A Botturi; A Silvani; E Lamperti; P Gaviani; A Innocenti; C Y Finocchiaro; M Masiero; G Pravettoni
Journal:  Support Care Cancer       Date:  2015-03-12       Impact factor: 3.603

Review 8.  Controversies concerning the application of brachytherapy in central nervous system tumors.

Authors:  Bo-Lin Liu; Jin-Xiang Cheng; Xiang Zhang; Wei Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

9.  Relationship between inflammatory cytokines and risk of depression, and effect of depression on the prognosis of high grade glioma patients.

Authors:  Jian-tong Jiao; Jun Sun; Jian-fen Ma; Min-chao Dai; Jin Huang; Chen Jiang; Cheng Wang; Chao Cheng; Jun-fei Shao
Journal:  J Neurooncol       Date:  2015-07-28       Impact factor: 4.130

10.  Evaluation of neuropsychological outcome and "quality of life" after glioma surgery.

Authors:  Julia Wolf; Benito Campos; Thomas Bruckner; Lidia Vogt; Andreas Unterberg; Rezvan Ahmadi
Journal:  Langenbecks Arch Surg       Date:  2016-03-30       Impact factor: 3.445
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.